Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Drug Safety|November 26, 2008
Role of cytochrome P450 polymorphisms in the development of pulmonary drug toxicity: a case-control study in the NetherlandsPetal A H M Wijnen, Marjolein Drent, Patty J Nelemans, et al.Pharmacoepidemiology and Drug Safety|July 18, 2015
Use of dipeptidyl peptidase 4 inhibitors and fracture risk compared to use of other anti-hyperglycemic drugsJohanna H M Driessen, Hein A W van Onzenoort, Jakob Starup-Linde, et al.Bone|August 6, 2014
Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fractureJohanna H M Driessen, Hein A W van Onzenoort, Ronald M A Henry, et al.Current Drug Safety|November 13, 2013
Use of biguanides and the risk of colorectal cancer: a register-based cohort studyLotte M Knapen, Suzanne T A M Dittrich, Frank de Vries, et al.Calcified Tissue International|July 18, 2015
Use of Glucagon-Like-Peptide 1 Receptor Agonists and Risk of Fracture as Compared to Use of Other Anti-hyperglycemic DrugsJohanna H M Driessen, Hein A W van Onzenoort, Jakob Starup-Linde, et al.Journal of Hypertension|December 3, 2009
Effect of self-measurement of blood pressure on adherence to treatment in patients with mild-to-moderate hypertensionHein A W van Onzenoort, Willem J Verberk, Abraham A Kroon, et al.Calcified Tissue International|April 21, 2015
Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysisJohanna H M Driessen, Ronald M A Henry, Hein A W van Onzenoort, et al.Clinical Therapeutics|November 15, 2011
Pharmacokinetics and tolerability of nasal versus intravenous midazolam in healthy Dutch volunteers: a single-dose, randomized-sequence, open-label, 2-period crossover pilot studyNicole M L Veldhorst-Janssen, Audrey A A Fiddelers, Paul-Hugo M van der Kuy, et al.Advances in Therapy|October 5, 2018
A Novel Ileocolonic Release Peppermint Oil Capsule for Treatment of Irritable Bowel Syndrome: A Phase I Study in Healthy VolunteersZsa Zsa R M Weerts, Daniel Keszthelyi, Lisa Vork, et al.Clinical Therapeutics|August 4, 2010
Pharmacokinetics, analgesic effect, and tolerability of a single preprocedural dose of intranasal fentanyl in patients undergoing drain removal after breast reduction or augmentation surgery: A prospective, randomized, double-blind, placebo-controlled studyNicole M L Veldhorst-Janssen, Audrey A A Fiddelers, Paul-Hugo M van der Kuy, et al.Pageof 6